Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
  • Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a company name.

Allena Pharmaceuticals Inc.

Headquarters: Newton, MA, United States of America
Year Founded: 2011
Status: Public
Industry Sector: HealthTechnology
CEO: Louis Brenner, MD, MBA
Number Of Employees: N/A
Enterprise Value: N/A
PE Ratio: 0
Exchange/Ticker 1: Pink:ALNAQ
Exchange/Ticker 2: N/A
Latest Market Cap: $100

BioCentury | Jun 7, 2023
Finance

June 7 Quick Takes: Radiopharma play ITM raises €255M

Plus: LNP company Hopewell emerges with $25M seed round and updates from Mozart, GSK, FibroGen and Deerfield
BioCentury | Nov 16, 2022
Management Tracks

Bungay becomes CEO at Imophoron, Garzoni transitions to CSO

Plus: Tracy named CTO at Code, and updates from ConcertAI, Lucy, Trevi and more
BioCentury | Dec 3, 2020
Management Tracks

Management Tracks: Zai taps Sandler as cancer head, plus moves at FibroGen, Arena, Samumed, Avita, Mersana, Frequency, Matinas, NeuBase, Allena and RA 

Zai Lab Ltd. (NASDAQ:ZLAB; HKEX:9688) hired Alan Sandler as president, head of global development, oncology, a newly created position. Sandler was SVP and global head of product development oncology
BioCentury | Oct 1, 2020
Product Development

Sept. 30 Quick Takes: $234M for NIH’s RADx-UP; plus CureVac, Allena, Covaxx

NIH in push to improve COVID-19 testing for underserved populationsThe National Institutes of Health has awarded about $234 million to improve COVID-19 testing for underserved and vulnerable
BioCentury | Jan 5, 2019
Company News

Flurry of management moves on eve of JPM

BioCentury | Jan 13, 2018
Finance

Choosy investors

Why 2018 will be a stock picker’s market in biotech
BioCentury | Nov 3, 2017
Financial News

Allena raises $74.7M IPO

BioCentury | Nov 2, 2017
Financial News

Spero sags after $77M listing

BioCentury | Nov 2, 2017
Financial News

Allena slips after pricing $74.7M IPO

BioCentury | Oct 13, 2017
Financial News

Allena proposes $92M IPO

Items per page:
1 - 10 of 30